Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by ProtoKinetix, Incorporated

Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication
From ProtoKinetix, Incorporated
Via Business Wire
Tickers PKTX
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants
From ProtoKinetix, Incorporated
Via Business Wire
Tickers PKTX
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only
From ProtoKinetix, Incorporated
Via Business Wire
Tickers PKTX
ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease
From ProtoKinetix, Incorporated
Via Business Wire
Tickers PKTX
ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions
From ProtoKinetix, Incorporated
Via Business Wire
Tickers PKTX
ProtoKinetix Announces the Resumption of Phase 1b Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 Diabetes
From ProtoKinetix, Incorporated
Via Business Wire
Tickers PKTX
ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®
From ProtoKinetix, Incorporated
Via Business Wire
Tickers PKTX
Journal of Tissue Engineering and Regenerative Medicine Publishes Peer Reviewed Research Paper Establishing ProtoKinetix AAGP® Enhanced Stem Cell Vision Restoration
From ProtoKinetix, Incorporated
Via Business Wire
Tickers PKTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.